Blood Pressure最新文献

{"title":"The Hypertension Excellence Centre programme of the European Society of Hypertension - current status, activities and reshaping for the future.","authors":"Thomas Weber, Michael Doumas, Christian Delles, Bojan Jelakovic, Margus Viigimaa, Krzysztof Narkiewicz, Andrzej Januszewicz, Reinhold Kreutz, Guido Grassi, Giuseppe Mancia","doi":"10.1080/08037051.2023.2269431","DOIUrl":"10.1080/08037051.2023.2269431","url":null,"abstract":"<p><strong>Purpose: </strong>To describe the history of the Excellence Centre (EC) programme of the European Society of Hypertension (ESH) since the beginning in 2006, its achievements, and its future developments.</p><p><strong>Materials and methods: </strong>We list the number of ECs per country, the research projects performed so far, and the organisational steps needed to reshape the EC programme for the future.</p><p><strong>Results: </strong>In August 2023, the ESH EC programme includes 118 registered ECs in 21 European and 7 non-European countries. Updates about the formal steps for application, re-application, transfer of EC and retirement of EC heads are given.</p><p><strong>Conclusions: </strong>The EC programme of the ESH has been a success from the beginning. Further refinements will make it fit for the next decades.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":"32 1","pages":"2269431"},"PeriodicalIF":1.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41190297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genetic and stress influences on the prevalence of hypertension among hispanics/latinos in the hispanic community health study/study of latinos (HCHS/SOL).","authors":"Liana K Preudhomme,&nbsp;Marc D Gellman,&nbsp;Nora Franceschini,&nbsp;Krista M Perreira,&nbsp;Lindsay E Fernández-Rhodes,&nbsp;Linda C Gallo,&nbsp;Carmen R Isasi,&nbsp;Sylvia Smoller,&nbsp;Sheila F Castañeda,&nbsp;Martha Daviglus,&nbsp;Christina Hutten,&nbsp;Richard S Cooper,&nbsp;Jianwen Cai,&nbsp;Neil Schneiderman,&nbsp;Maria M Llabre","doi":"10.1080/08037051.2022.2091977","DOIUrl":"https://doi.org/10.1080/08037051.2022.2091977","url":null,"abstract":"<p><strong>Purpose: </strong>The current study examined the effects of chronic stress and a genetic risk score on the presence of hypertension and elevated systolic blood pressure and diastolic blood pressure among Hispanics/Latinos in the target population of Hispanic Community Health Study/Study of Latinos.</p><p><strong>Materials and methods: </strong>Of the participants (<i>N</i> = 11,623) assessed during two clinic visits (Visit 1 2008-2013 & Visit 2 2014-2018), we analysed data from 7,429 adults (50.4% female), aged 18-74, who were genotyped and responded to chronic stress questionnaires. We calculated an unweighted genetic risk score using blood pressure increasing single nucleotide polymorphisms (SNPs) found to be generalisable to Hispanics/Latinos (10 SNPs). Linear and logistic regression models were used to estimate associations between chronic stress and genetic risk score and their interaction, with prevalent Visit 2 SBP or DBP, and hypertension, respectively. Models accounted for sampling weights, stratification, and cluster design.</p><p><strong>Results: </strong>Chronic stress (adjusted OR = 1.18, 95%CI:1.15,1.22) and hypertension genetic risk score (adjusted OR = 1.04, 95%CI:1.01,1.07) were significantly associated with prevalent hypertension, but there was no significant interaction between the chronic stress and genetic risk score on hypertension (<i>p</i> = .49). genetic risk score (<i>b</i> = .32, 95%CI:.08, .55, <i>R</i>² = .02) and chronic stress (<i>b</i> = .45, 95%CI:.19, .72, <i>R</i>² = .11) were related to DBP, with no significant interaction (<i>p</i> = .62). Genetic risk score (<i>b</i> = .42, 95%CI:.08, .76, <i>R</i>² = .01) and chronic stress (<i>b</i> = .80, 95%CI:.34,1.26, <i>R</i>² = .11) were also related to SBP, with no significant interaction (<i>p</i> = .51).</p><p><strong>Conclusion: </strong>Results demonstrate the utility of a genetic risk score for blood pressure and are consistent with literature suggesting chronic stress has a strong, direct association with elevated blood pressure among U.S. Hispanics/Latinos.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"155-163"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40406752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Masked arterial hypertension in a 64-year-old man with primary aldosteronism.","authors":"Joanna Kanarek-Kucner,&nbsp;Beata Graff,&nbsp;Vlasta Bari,&nbsp;Rufus Barraclough,&nbsp;Krzysztof Narkiewicz,&nbsp;Michał Hoffmann","doi":"10.1080/08037051.2021.2003699","DOIUrl":"https://doi.org/10.1080/08037051.2021.2003699","url":null,"abstract":"<p><strong>Purpose: </strong>Primary aldosteronism is one of the most frequent causes of secondary arterial hypertension, and whether primary aldosteronism is associated with masked hypertension is unknown.</p><p><strong>Materials and methods: </strong>We describe a 64-year-old man with a history of hypothyroidism, recurring hypokalaemia, and normal home and office blood pressure values. Ambulatory blood pressure monitoring revealed masked hypertension with strikingly high systolic blood pressure variability and typical hypertension-mediated organ damage.</p><p><strong>Results: </strong>The patient required gradual escalation of antihypertensive medication to four drugs. During the diagnostic process we identified primary aldosteronism, cobalamin deficiency, severe obstructive sleep apnoea, and low baroreflex sensitivity (1.63 ms/mmHg). Following unilateral adrenalectomy, cobalamin supplementation and continuous positive airway pressure, we observed a spectacular improvement in the patient's blood pressure control, baroreflex sensitivity (4.82 ms/mmHg) and quality of life.</p><p><strong>Conclusions: </strong>We report an unusual case of both masked arterial hypertension and primary aldosteronism. Elevated blood pressure values were masked in home and office measurements by coexisting hypotension which resulted most probably from deteriorated baroreflex sensitivity. Baroreflex sensitivity increased following treatment, including unilateral adrenalectomy. Hypertension can be masked by coexisting baroreceptor dysfunction which may derive from structural but also functional reversible changes.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"4-8"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39928057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"War, hypertension and post traumatic stress disorder. A personal experience.","authors":"Luís Bronze","doi":"10.1080/08037051.2022.2118661","DOIUrl":"https://doi.org/10.1080/08037051.2022.2118661","url":null,"abstract":"","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"225-227"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33454531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Blood pressure control measures and cardiovascular outcomes: a prospective hypertensive cohort.","authors":"Konstantinos Sideris,&nbsp;Ioannis Andrikou,&nbsp;Costas Thomopoulos,&nbsp;Fotis Tatakis,&nbsp;Maria Kariori,&nbsp;Eleni Manta,&nbsp;Theodoros Kalos,&nbsp;Stergios Soulaidopoulos,&nbsp;Sotirios Drogkaris,&nbsp;Dimitris Konstantinidis,&nbsp;Konstantinos Tsioufis","doi":"10.1080/08037051.2022.2118662","DOIUrl":"https://doi.org/10.1080/08037051.2022.2118662","url":null,"abstract":"<p><strong>Purpose: </strong>We investigated whether blood pressure (BP) control measures, visit-to-visit BP variability, and time in therapeutic range (TTR) are associated with future cardiovascular outcomes in hypertensive patients.</p><p><strong>Materials and methods: </strong>Among 1,408 hypertensive patients without cardiovascular disease, we prospectively evaluated the incident major cardiovascular events over 6 years. In newly diagnosed patients, antihypertensive drug treatment was initiated. We estimated two markers of on-treatment BP control, (1) visit-to-visit BPV as the coefficient of variation of office systolic BP (BP-CV), and (2) TTR calculated as the percentage of office systolic BP measurements within 120-140mmHg across visits.</p><p><strong>Results: </strong>The hypertensive cohort (672 males, mean age 60 years, 31% newly diagnosed) had a mean systolic/diastolic BP of 142/87 mmHg. The mean number of visits was 4.9 ± 2.6, while the mean attained systolic/diastolic BP during follow-up was 137/79 mmHg using 2.7 ± 1.1 antihypertensive drugs. The BP-CV and TTR were 9.1 ± 4.1% and 45 ± 29%, respectively, and the incidence of the composite outcome was 8.3% (<i>n</i> = 117). After adjustment for relevant confounders and standardization to z-scores, BP-CV and TTR were associated with a 43% (95% CI, 27-62%) increase and a 33% (95% CI, 15-47%) reduction in the outcome. However, the joint evaluation of TTR and BP-CV in a common multivariable model indicated that a standardized change of TTR was associated with the outcome to a greater extent than BP-CV (mean hazard ratios of 30% vs. 24%, respectively). When combined with the higher BP standardized-CV quartile, the lower TTR quartile predicted the outcome by 2.3 times (95% CI, 1.1-5.4) compared to the inverse TTR and BP-CV quartile pattern.</p><p><strong>Conclusion: </strong>High BP-CV or low TTR was associated with future cardiovascular events in a cohort of treated hypertensive patients. As a determinant, the extent of TTR value appears greater than BP-CV when these measures are considered in the same multivariable model.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"228-235"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40370242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Continuous cuffless and non-invasive measurement of arterial blood pressure-concepts and future perspectives.","authors":"Niklas Pilz,&nbsp;Andreas Patzak,&nbsp;Tomas L Bothe","doi":"10.1080/08037051.2022.2128716","DOIUrl":"https://doi.org/10.1080/08037051.2022.2128716","url":null,"abstract":"<p><p>Hypertension diagnosis is one of the most common and important procedures in everyday clinical practice. Its applicability depends on correct and comparable measurements. Cuff-based measurement paradigms have dominated ambulatory blood pressure (BP) measurements for multiple decades. Cuffless and non-invasive methods may offer various advantages, such as a continuous and undisturbing measurement character. This review presents a conceptual overview of recent advances in the field of cuffless measurement paradigms and possible future developments which would enable cuffless beat-to-beat BP estimation paradigms to become clinically viable. It was refrained from a direct comparison between most studies and focussed on a conceptual merger of the ideas and conclusions presented in landmark scientific literature. There are two main approaches to cuffless beat-to-beat BP estimation represented in the scientific literature: First, models based on the physiological understanding of the cardiovascular system, mostly reliant on the pulse wave velocity combined with additional parameters. Second, models based on Deep Learning techniques, which have already shown great performance in various other medical fields. This review wants to present the advantages and limitations of each approach. Following this, the conceptional idea of unifying the benefits of physiological understanding and Deep Learning techniques for beat-to-beat BP estimation is presented. This could lead to a generalised and uniform solution for cuffless beat-to-beat BP estimations. This would not only make them an attractive clinical complement or even alternative to conventional cuff-based measurement paradigms but would substantially change how we think about BP as a fundamental marker of cardiovascular medicine.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"254-269"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40388492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Associations of urinary orosomucoid, N-acetyl-β-D-glucosaminidase, and albumin with blood pressure and hypertension after 7 years. The Tromsø Study.","authors":"Karl M Brobak,&nbsp;Runa M Andreassen,&nbsp;Toralf Melsom,&nbsp;Aud Høieggen,&nbsp;Jon V Norvik,&nbsp;Marit D Solbu","doi":"10.1080/08037051.2022.2128043","DOIUrl":"https://doi.org/10.1080/08037051.2022.2128043","url":null,"abstract":"<p><p><b>Purpose:</b> Subclinical chronic kidney disease is known to exacerbate hypertension and progression of kidney damage. In order to initiate timely interventions, early biomarkers for this vicious circle are needed. Our aim was to describe the cross-sectional associations of urinary orosomucoid and urinary N-acetyl-β-D-glucosaminidase (NAG) with blood pressure and the longitudinal associations of urinary orosomucoid and NAG to hypertension after 7 years, and to compare the strength of these associations to the urinary albumin excretion (UAE).<b>Material and methods:</b> The Tromsø Study is a population-based, prospective study of inhabitants of the municipality of Tromsø, Northern Norway. Morning spot urine samples were collected on three consecutive days in the Tromsø 6 survey (2007-2008). We assessed the cross-sectional associations of urinary orosomucoid, NAG and UAE with blood pressure in Tromsø 6. In a cohort of participants attending Tromsø 6 and Tromsø 7 (2015-2016), we studied whether urinary biomarkers were longitudinally associated with hypertension.<b>Results:</b> A total of 7197 participants with a mean age of 63.5 years (<i>SD</i> 9.2), and a mean blood pressure of 141/78 mmHg (<i>SD</i> 23.0/10.6), were included in the study. Orosomucoid and UAE, but not NAG, was significantly associated with systolic and diastolic blood pressure in all the crude and multivariable cross-sectional analyses. Orosomucoid had consistently, although marginally, stronger associations with blood pressure. Incident hypertension at follow-up (Tromsø 7) was consistently significantly associated with urinary orosomucoid, but not urinary NAG or UAE. However, the standardized regression coefficients for orosomucoid were only marginally stronger than the standardized regression coefficients for ACR.<b>Conclusion:</b> In a cohort from the general population urine orosomucoid had a stronger cross-sectional association with blood pressure than UAE. After 7 years, urine orosomucoid showed the strongest association with incident hypertension. There were varying and weak associations between U-NAG, blood pressure and hypertension.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"270-283"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33487172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Blood pressure telemonitoring and telemedicine for hypertension management-positions, expectations and feasibility of Latin-American practitioners. SURVEY carried out by several cardiology and hypertension societies of the Americas.","authors":"Daniel Piskorz,&nbsp;Luis Alcocer Díaz-Barreiro,&nbsp;Ricardo López Santi,&nbsp;Ana Múnera,&nbsp;Dora Inés Molina,&nbsp;Weimar Sebba Barroso,&nbsp;Fernando Wyss,&nbsp;Carlos Ponte Negretti,&nbsp;Héctor Galván Oseguera,&nbsp;Silvia Palomo,&nbsp;Enrique Díaz-Díaz,&nbsp;Martín Rosas Peralta,&nbsp;Adolfo Chávez Mendoza,&nbsp;Humberto Alvarez Lopez,&nbsp;Sebastián García Zamora,&nbsp;Ernesto Peñaherrera Patiño,&nbsp;Arturo Guerra López,&nbsp;Adriana Puente Barragan","doi":"10.1080/08037051.2022.2123781","DOIUrl":"https://doi.org/10.1080/08037051.2022.2123781","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the opinion of Latin-American physicians on remote blood pressure monitoring and telehealth for hypertension management.</p><p><strong>Material and methods: </strong>Cross-sectional survey of physicians residing in Latin-America. The study was conducted by the Mexico Hypertension Experts Group, Interamerican Society of Hypertension, Interamerican Society of Cardiology Epidemiology and Cardiovascular Prevention Council, and National Cardiologist Association of Mexico. An online survey composed of 40 questions using Google Forms was distributed from 7 December 2021, to 3 February 2022. The survey was approved by the GREHTA Ethics Committee and participation was voluntary and anonymous. Multiple logistic regression models were constructed to identify the challenges of telehealth.</p><p><strong>Results: </strong>1753 physicians' responses were gathered. The responses came from physicians from different Latin-American countries, as follows: 24% from Mexico, 20.6% from Argentina, 14.7% from Colombia, 10.9% from Brazil, 8.7% from Venezuela, 8.2% from Guatemala and 3.2% from Paraguay. Responders with a high interest in carrying out their assistance task through remote telemonitoring reached 48.9% (821), while 43.6% are already currently conducting telemonitoring. A high number, 62%, claimed to need telemonitoring training. There is a direct relation between higher interest in telemonitoring and age, medical specialty, team working, residence in the biggest cities, expectations regarding telemedicine and reimbursement.</p><p><strong>Conclusions: </strong>Remote monitoring is feasible in Latin-America. General practitioners and specialists from bigger cities seem eager and are self-perceived as well-trained and experienced. Facilities and resources do not seem to be a challenge but training reinforcement and telemedicine promotion is necessary for those physicians less motivated.PLAIN LANGUAGE SUMMARYWhat is the context?Hypertension is one of the leading worldwide modifiable risk factors for premature death. Strong evidence supports that effective treatment of this condition results in a significant reduction of hard outcomes.Only 20%-30% of hypertensive patients are within the blood pressure targets recommended by guidelines in Latin-America. There is an urgent need to implement innovative strategies to reverse this alarming health situation.What is new?Latin-American physicians were highly predisposed to telemonitoring practice. This high motivation was not influenced by hardware or software availability, technological knowledge or experience, by volume of monthly consultations, or by area (private-public) where the care activity is carried out.This high motivation may be supported by the conviction that this practice could be very useful as a complement to face-to-face assistance and a highly effective tool to improve adherence even though respondents considered that just 10% of the patients would prefer telemonito","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"236-244"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40370764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High-frame-rate A-mode ultrasound for calibration-free cuffless carotid pressure: feasibility study using lower body negative pressure intervention.","authors":"Kiran V Raj,&nbsp;P M Nabeel,&nbsp;Dinu Chandran,&nbsp;Mohanasankar Sivaprakasam,&nbsp;Jayaraj Joseph","doi":"10.1080/08037051.2021.2022453","DOIUrl":"https://doi.org/10.1080/08037051.2021.2022453","url":null,"abstract":"<p><strong>Purpose: </strong>Existing technologies to measure central blood pressure (CBP) intrinsically depend on peripheral pressure or calibration models derived from it. Pharmacological or physiological interventions yielding different central and peripheral responses compromise the accuracy of such methods. We present a high-frame-rate ultrasound technology for cuffless and calibration-free evaluation of BP from the carotid artery. The system uses a pair of single-element ultrasound transducers to capture the arterial diameter and local pulse wave velocity (PWV) for the evaluation of beat-by-beat BP employing a novel biomechanical model.</p><p><strong>Materials and methods: </strong>System's functionality assessment was conducted on eight male subjects (26 ± 4 years, normotensive and no history of cardiovascular risks) by perturbing pressure <i>via</i> short-term moderate lower body negative pressure (LBNP) intervention (-40 mmHg for 1 min). The ability of the system to capture dynamic responses of carotid pressure to LBNP was investigated and compared against the responses of peripheral pressure measured using a continuous BP monitor.</p><p><strong>Results: </strong>While the carotid pressure manifested trends similar to finger measurements during LBNP, the system also captured the differential carotid-to-peripheral pressure response, which corroborates the literature. The carotid diastolic and mean pressures agreed with the finger pressures (limits-of-agreement within ±7 mmHg) and exhibited acceptable uncertainty (mean absolute errors were 2.4 ± 3.5 and 2.6 ± 4.0 mmHg, respectively). Concurrent to the literature, the carotid systolic and pulse pressures (PPs) were significantly lower than those of the finger pressures by 11.1 ± 9.4 and 11.3 ± 8.2 mmHg, respectively (<i>p</i> < .0001).</p><p><strong>Conclusions: </strong>The study demonstrated the method's potential for providing cuffless and calibration-free pressure measurements while reliably capturing the physiological aspects, such as PP amplification and dynamic pressure responses to intervention.</p>","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"19-30"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39686580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A 30th anniversary and a glimpse of the future.","authors":"Michel Burnier,&nbsp;Sverre E Kjeldsen","doi":"10.1080/08037051.2021.2021638","DOIUrl":"https://doi.org/10.1080/08037051.2021.2021638","url":null,"abstract":"In 1992, Lennart Hansson, Sverker Jern and Thomas Hedner, three enthusiastic and enterprising clinicians interested in hypertension research decided to create a new journal, which they entitled BLOOD PRESSURE (Figure 1). Their main objective was to ‘facilitate the communication of research findings as effectively as possible in order to stimulate exchange of new ideas and thereby initiate further progress’ [1]. As mentioned in their first editorial, the ambition was also to emphasise on clinical rather than on basic research. Initially, BLOOD PRESSURE was printed by Scandinavian University Press, a publishing company resulting from the merge of a Norwegian and a Swedish publisher, but today, after a consolidation within the scientific publishing sector, Taylor and Francis Ltd. is the official publisher of the journal. While celebrating its 30-year anniversary in 2022, founders of BLOOD PRESSURE could be proud of the development of their journal. Indeed, over the years, BLOOD PRESSURE has witnessed an increasing popularity as a publisher of highimpact clinical research, which is reflected by a steadily rising impact factor, this latter having increased more than two-fold between 2010 and 2020 to reach 2.83. Several factors have contributed to the successful development of the journal. The first was undoubtedly the great contribution of Scandinavian investigators who covered a wide range of important hypertension topics from basic physiology, with world experts like Prof. Bj€ orn Folkow [2], to drug development and large clinical outcome studies with trial experts like Profs. Lennart Hansson, Bj€ orn Dahl€of, Hans Ibsen, Lars Lindholm, Per Lund-Johansen and Sverre E. Kjeldsen. Indeed, the development and the participation in large clinical morbidity and mortality trials in hypertension has become a ‘specialty’ of Nordic countries, which were perfectly organised and experienced to run such large trials. Thus, over the years, numerous outcome studies in hypertension were conducted in Scandinavia. These included for example STOP, STOP-2, CAPPP, NORDIL, HOT, LIFE, VALUE, ASCOT and ACCOMPLISH though with time large fractions of patients were also included in UK, USA and in other countries. Although results of these trials were always published in the Lancet or the New England Journal of Medicine, BLOOD PRESSURE benefitted a lot from these studies. In this respect, one reference article, published in BLOOD PRESSURE in 1992, is the first description of the PROBE (Prospective Randomised Open Blinded Endpoint) design for large clinical outcome trials, a method that became rapidly adopted for use in several large clinical morbidity and mortality outcome studies [3]. Papers describing protocols, including background, randomised populations and progress reports were frequently published in BLOOD PRESSURE. The second major factor is certainly the tight link between the journal and the European Society of Hypertension (ESH). From its introduction, the journal en","PeriodicalId":9000,"journal":{"name":"Blood Pressure","volume":" ","pages":"1-3"},"PeriodicalIF":1.8,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39844929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}